Global Anti-Obesity Drugs Market Size, Share, Growth Forecast 2032
Global anti-obesity drugs market is projected to witness a CAGR of 21.21% during the forecast period 2025–2032, growing from USD 8.15 billion in 2024 to USD 37.95 billion in 2032. The market is being driven by the global surge in obesity rates, rising demand for advanced GLP-1 and multi-target drugs, and favorable regulatory and reimbursement frameworks. Rapid innovations in drug discovery and delivery technologies are enhancing treatment efficacy. Additionally, North America’s strong healthcare infrastructure and policy support are reinforcing market dominance.
https://www.marketsandata....
Global anti-obesity drugs market is projected to witness a CAGR of 21.21% during the forecast period 2025–2032, growing from USD 8.15 billion in 2024 to USD 37.95 billion in 2032. The market is being driven by the global surge in obesity rates, rising demand for advanced GLP-1 and multi-target drugs, and favorable regulatory and reimbursement frameworks. Rapid innovations in drug discovery and delivery technologies are enhancing treatment efficacy. Additionally, North America’s strong healthcare infrastructure and policy support are reinforcing market dominance.
https://www.marketsandata....
11:33 AM - May 15, 2025 (UTC)
